Stoke Therapeutics, Inc. (STOK)

34.42 +0.64 (+1.89%) USD  |  NASDAQ  |  Mar 04, 16:00
34.00 -0.42 (-1.22%) Pre-Market: 08:10
More

Stoke Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for STOK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Scholar Rock Holding Corp. --
Zymeworks, Inc. Upgrade
Moderna, Inc. Upgrade